MAGE-A is More Highly Expressed Than NY-ESO-1 in a Systematic Immunohistochemical Analysis of 3668 Cases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

MAGE-A is More Highly Expressed Than NY-ESO-1 in a Systematic Immunohistochemical Analysis of 3668 Cases

Published:2016-05 Issue:4 Volume:39 Page:181-187
ISSN:1524-9557
Container-title:Journal of Immunotherapy
language:en
Short-container-title:

Author:

Kerkar Sid P.,Wang Zeng-Feng,Lasota Jerzy,Park Tristen,Patel Krishna,Groh Eric,Rosenberg Steven A.,Miettinen Markku M.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology,Immunology,Immunology and Allergy

Reference27 articles.

1. Cancer/testis antigens, gametogenesis and cancer;Simpson;Nat Rev Cancer,2005

2. The cancer/testis genes: review, standardization, and commentary;Scanlan;Cancer Immun,2004

3. Tumor-specific shared antigenic peptides recognized by human T cells;Van Der Bruggen;Immunol Rev,2002

4. Expression of New York esophageal squamous cell carcinoma-1 in primary and metastatic melanoma;Aung;Hum Pathol,2014

5. NY-ESO-1 expression in synovial sarcoma and other mesenchymal tumors: significance for NY-ESO-1-based targeted therapy and differential diagnosis;Lai;Mod Pathol,2012

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene and Protein Expression of MAGE and Associated Immune Landscape Elements in Non–Small-Cell Lung Carcinoma and Urothelial Carcinomas;Journal of Immunotherapy;2024-08-22

2. Mechanisms of tumor immunosuppressive microenvironment formation in esophageal cancer;World Journal of Gastroenterology;2024-04-28

3. Potential role of immune cell therapy in gynecological cancer and future promises: a comprehensive review;Medical Oncology;2024-03-27

4. TCR-engineered T-cells directed against Ropporin-1 constitute a safe and effective treatment for triple-negative breast cancer in near-clinical models;2024-01-11

5. Fusion of NY-ESO-1 epitope with heat shock protein 70 enhances its induced immune responses and antitumor activity against glioma in vitro;Translational Cancer Research;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3